Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injury

Abstract Background Glaucoma is a leading cause of blindness characterized by retinal ganglion cell (RGC) degeneration. SA-10, a dual-acting compound with ROS scavenging and NO-donating properties, was evaluated to enhance RGC survival and function in models of oxidative stress, ischemia/reperfusion...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jennifer H. Pham, Wei Zhang, Kim-Tuyen T. Le, Bindu Kodati, Charles E. Amankwa, Biddut DebNath, Gretchen A. Johnson, Thien T. Bui, Rachel Y. Gitter, Jonah P. Gutierrez, Brendon R. Hatfield, Rojan Satyal, Ella R. Sinnott, Raghu R. Krishnamoorthy, Suchismita Acharya, Dorota L. Stankowska
Format:	Article
Language:	English
Published:	BMC 2025-08-01
Series:	BMC Neuroscience
Subjects:	Neuroprotection Glaucoma Retinal ganglion cells Oxidative stress Reactive oxygen species Antioxidants
Online Access:	https://doi.org/10.1186/s12868-025-00971-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Hybrid molecule SA-10 and its PLGA nanosuspension protect human and rodent retinal ganglion cells against neuronal injury

Similar Items